Neonatal microglia replacement in mice modulates seizure severity in adulthood

Carleigh A O'Brien1, Samuelle A S Delcy2, Sangeeta Shukla3

  • 1Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Insights

Early life microglia depletion worsens brain injury, but replacement with monocytes can restore function. Donor microglia transfer did not improve outcomes, highlighting the importance of cell origin in microglia replacement therapy for pediatric neurologic diseases.

Area of Science:

  • Neuroscience
  • Immunology
  • Developmental Biology

Background:

  • Microglia replacement therapy is a promising approach for pediatric neurologic diseases.
  • The long-term effects of early-life microglia manipulation on neural circuits are not well understood.

Purpose of the Study:

  • To investigate the durable impacts of early postnatal microglia depletion and adoptive macrophage transfer on neural circuits in a mouse model.
  • To determine how different macrophage populations affect brain responses to excitotoxic challenge.

Main Methods:

  • Established pharmacologic and genetic models for neonatal microglia depletion and replacement.
  • Utilized a chemical seizure model to assess seizure severity, mortality, and neuropathology.
  • Performed RNA sequencing on transplanted microglia, monocyte-derived surrogates, and endogenous microglia.

Main Results:

  • Postnatal microglia depletion exacerbated seizure severity, mortality, and neuropathology in adult mice.
  • Adoptive transfer of monocytes rescued the detrimental effects of microglia depletion.
  • Transfer of donor microglia did not rescue, and even worsened, seizure phenotypes.
  • RNA sequencing revealed distinct transcriptional responses of different macrophage populations to excitotoxic insult.

Conclusions:

  • Neonatal microglia depletion has lasting negative effects on the brain.
  • Monocyte-derived macrophages can effectively replace endogenous microglia and restore function.
  • The ontogeny and source of macrophages significantly influence their response to brain injury.
  • Findings provide critical insights for the preclinical development of microglia replacement therapies.

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...